News

Virtual Hackathon of CEF projects

Published on | 3 years ago

Programmes Climate, Energy, Mobility

The consortia of the Dydas & Spotted projects (co-financed by the CEF) are organising a virtual hackathon.

The CEF Projects Virtual Hackathon is a competition for innovative ideas aimed at developing new smart services/solutions/applications in the sector of Smart Mobility, Urban Green Areas Management, and Open Data (including Satellite Data and Earth Observation Data).

Two main challenges are proposed: 

  • DYDAS consortium: Smart Mobility & Smart Cities (Shed Light-on red traffic lights)
  • SPOTTED consortium: Satellite & Open Data (Shed Light-on urban greenery status)

Selected solutions will be presented in front of a jury, with prizes up to €5.000 for each challenge.

The deadline to submit is January 17, 2023.

More information (challenge details, etc.) can be found on the main website. A detailed terms and conditions is also available here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1772 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.